Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CASI
#3957
CASI Pharmaceuticals, Inc. Ordinary Shares
0.2
1
-73.75%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-73.75%
Monthly Change
-78.79%
6 month change
-90.41%
Year Change
-91.36%
Previous Close
0.8
0
Open
0.2
1
Bid
Ask
Low
0.2
1
High
0.2
1
Volume
17
Markets
US Stock Market
Healthcare
CASI
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2022
2023
2024
TTM
Cash from operating activities
21.09 M
19.97 M
29.2 M
—
Cash from investing activities
31.16 M
9.67 M
11.24 M
—
Cash from financing activities
3.27 M
907 K
15.43 M
—
Free cash flow
15.48 M
17.73 M
28.96 M
—
News
What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%
美国股市上涨;截至收盘道琼斯工业平均指数上涨0.63%
CASI Pharmaceuticals因纳斯达克摘牌通知股价暴跌
CASI Pharmaceuticals stock plunges on Nasdaq delisting notice
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
中国批准凯赛制药的CID-103用于肾脏排斥反应的临床试验
China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection
CASI制药公司获纳斯达克延期上市许可后股价飙升
CASI制药获纳斯达克延期上市至2026年2月
CASI Pharmaceuticals stock surges after Nasdaq grants listing extension